DSGN
Price
$9.39
Change
+$0.02 (+0.21%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
534.89M
109 days until earnings call
Intraday BUY SELL Signals
VTYX
Price
$10.00
Change
+$0.01 (+0.10%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
713.59M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs VTYX

Header iconDSGN vs VTYX Comparison
Open Charts DSGN vs VTYXBanner chart's image
Design Therapeutics
Price$9.39
Change+$0.02 (+0.21%)
Volume$8.11K
Capitalization534.89M
Ventyx Biosciences
Price$10.00
Change+$0.01 (+0.10%)
Volume$35.16K
Capitalization713.59M
DSGN vs VTYX Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. VTYX commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a StrongBuy and VTYX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (DSGN: $9.37 vs. VTYX: $9.99)
Brand notoriety: DSGN and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 140% vs. VTYX: 17%
Market capitalization -- DSGN: $534.89M vs. VTYX: $713.59M
DSGN [@Biotechnology] is valued at $534.89M. VTYX’s [@Biotechnology] market capitalization is $713.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 6 TA indicator(s) are bullish while VTYX’s TA Score has 2 bullish TA indicator(s).

  • DSGN’s TA Score: 6 bullish, 4 bearish.
  • VTYX’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than VTYX.

Price Growth

DSGN (@Biotechnology) experienced а +27.66% price change this week, while VTYX (@Biotechnology) price change was +5.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.81%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +75.56%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

VTYX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+8.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($714M) has a higher market cap than DSGN($535M). VTYX YTD gains are higher at: 356.164 vs. DSGN (51.864). DSGN has higher annual earnings (EBITDA): -74.31M vs. VTYX (-129.1M). DSGN (216M) and VTYX (209M) have equal amount of cash in the bank . DSGN has less debt than VTYX: DSGN (1.95M) vs VTYX (10.3M). DSGN (0) and VTYX (0) have equivalent revenues.
DSGNVTYXDSGN / VTYX
Capitalization535M714M75%
EBITDA-74.31M-129.1M58%
Gain YTD51.864356.16415%
P/E RatioN/AN/A-
Revenue00-
Total Cash216M209M103%
Total Debt1.95M10.3M19%
TECHNICAL ANALYSIS
Technical Analysis
DSGNVTYX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 25 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXCAX13.560.23
+1.73%
BlackRock Emerging Markets Ex-Chn Inv A
PRPPX16.530.18
+1.10%
Principal International Equity R3
OBSIX29.610.31
+1.06%
Oberweis Small-Cap Opportunities Instl
WMLIX36.780.25
+0.68%
Wilmington Large-Cap Strategy Instl
BUFGX39.730.08
+0.20%
Buffalo Growth

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-0.43%
IDYA - DSGN
52%
Loosely correlated
+1.10%
CRNX - DSGN
49%
Loosely correlated
+2.95%
WVE - DSGN
48%
Loosely correlated
+3.23%
VRDN - DSGN
48%
Loosely correlated
+0.99%
SYRE - DSGN
48%
Loosely correlated
+1.88%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-4.49%
KYMR - VTYX
43%
Loosely correlated
+2.76%
IPSC - VTYX
39%
Loosely correlated
+1.50%
REPL - VTYX
38%
Loosely correlated
+5.56%
AKRO - VTYX
38%
Loosely correlated
-0.02%
DSGN - VTYX
37%
Loosely correlated
-0.43%
More